Novartis has posted a healthy rise in sales and profits in the first full quarter since it separated from Sandoz and proposed former Bristol Myers Squibb’s chief executive Giovanni Caforio as its ...
This guidance updates and replaces NICE technology appraisal guidance on sodium zirconium cyclosilicate for treating hyperkalaemia (TA599). Next review: This guidance will be reviewed if there is new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results